Dimethyl fumarate induces necroptosis in colon cancer cells through GSH depletion/ROS increase/MAPKs activation pathway
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Background and Purpose: Dimethyl fumarate (DMF) is a newly approved drug for the treatment of relapsing forms of multiple sclerosis and relapsing‐remitting multiple sclerosis. Here, we investigated the effects of DMF and its metabolites mono‐methylfumarate (MMF and methanol) on different gastrointestinal cancer cell lines and the underlying molecular mechanisms involved. Experimental Approach: Cell viability was measured by the MTT or CCK 8 assay. Protein expressions were measured by Western blot analysis. LDH release, live‐ and dead‐cell staining, intracellular GSH levels, and mitochondrial membrane potential were examined by using commercial kits. Key Results: DMF but not MMF induced cell necroptosis, as demonstrated by the pharmacological tool necrostatin‐1, transmission electron microscopy, LDH and HMGB 1 release in CT 26 cells. The DMF‐induced decrease in cellular GSH levels as well as cell viability and increase in reactive oxygen species (ROS) were inhibited by co‐treatment with GSH and N‐acetylcysteine (NAC) in CT 26 cells. DMF activated JNK, p38 and ERK MAPKs in CT 26 cells and JNK, p38 and ERK inhibitors partially reversed the DMF‐induced decrease in cell viability. GSH or NAC treatment inhibited DMF‐induced JNK, p38, and ERK activation in CT 26 cells. DMF but not MMF increased autophagy responses in SGC‐7901, HC T116, HT 29 and CT 26 cancer cells, but autophagy inhibition did not prevent the DMF‐induced decrease in cell viability. Conclusion and Implications: DMF but not its metabolite MMF induced necroptosis in colon cancer cells through a mechanism involving the depletion of GSH, an increase in ROS and activation of MAPKs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068 · cited 1×
“Necroptosis is a necrotic-like, caspase-independent cell death that is characterized by loss of plasma membrane integrity, excessive autophagy, loss of mitochondria membrane potential and the generation of reactive oxygen species (ROS) is enhanced in necrotic cells (Degterev et al., 2005).”
BackgroundGalluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421 · cited 1×
“Cell necroptosis has different characteristics compared with cell apoptosis, both biochemically and morphologically, and has been well reviewed (Christofferson and Yuan, 2010; Galluzzi et al., 2012; Linkermann and Green, 2014).”
BackgroundMolecular mechanisms of necroptosis: an ordered cellular explosion
Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., & Kroemer, G. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2970 · Cited by 2,382 · cited 1×
“Necroptosis involves the active disintegration of mitochondrial membranes (Han et al., 2007; Vandenabeele et al., 2010).”
BackgroundIdentification of RIP1 kinase as a specific cellular target of necrostatins
Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.83 · Cited by 2,059 · cited 3×
“Nec, an inhibitor of receptor interacting protein-1 kinase, is a pharmacological tool used to identify cell necroptosis (Degterev et al., 2008); the dose of Nec needed to have this effect has been shown to range from 30 to 100 μM (Degterev et al.”
BackgroundMethodMammalian autophagy: core molecular machinery and signaling regulation
Yang, Z., & Klionsky, D. J. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.11.014 · Cited by 1,956 · cited 2×
“…Pharmacology (2015) 172 3929–3943 3939 Autophagy is a critical lysosomal process that maintains cellular homeostasis through the degradation of cellular components such as organelles and proteins, but when extensive, the autophagy response leads to autophagic cell death (Yang and Klionsky, 2010).”
BackgroundLinker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain · doi:10.1093/brain/awq386 · Cited by 1,155 · cited 2×
“…SB203580, or ERK inhibitor PD98059 for 1 h, then DMF(100 μM) was added until 24 h. 3938 British Journal of Pharmacology (2015) 172 3929–3943 and is implicated in a variety of disease states, such as stroke, atherosclerosis, ischaemia-reperfusion injury and pancreatitis (Linkermann and Green, 2014).”
BackgroundWu, Y.-T., Tan, H.-L., Shui, G., Bauvy, C., Huang, Q., Wenk, M. R., Ong, C.-N., Codogno, P., & Shen, H.-M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.080796 · Cited by 1,127 · cited 1×
“Our previous work and other studies have shown that 3-MA is not a stable autophagy inhibitor and has some non-specific effects (Wu et al., 2010; Sheng et al., 2013).”
ResultLinkermann, A., & Green, D. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1310050 · Cited by 1,103
p53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis
Vaseva, A. V., Marchenko, N. D., Ji, K., Tsirka, S. E., Holzmann, S., & Moll, U. M. (2012) · Cell · doi:10.1016/j.cell.2012.05.014 · Cited by 740 · cited 1×
“CsA inhibits mitochondrial permeability transition pore (MPTP) opening and attenuates necrotic damage (Petrosillo et al., 2009; Vaseva et al., 2012; Zhang et al., 2014).”
BackgroundBG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety
Fox, R. J., Kita, M., Cohan, S. L., Henson, L. J., Zambrano, J., Scannevin, R. H., O'Gorman, J., Novas, M., Dawson, K. T., & Phillips, J. T. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.849236 · Cited by 124 · cited 4×
“, Weston, MA, USA) was approved by the FDA and European Medicines Agency as a new oral drug for the treatment of relapsing forms of multiple sclerosis and relapsing-remitting multiple sclerosis (Burness and Deeks, 2014; Fox et al., 2014).”
BackgroundInfluential
Cited by
Reactive oxygen species and cancer paradox: To promote or to suppress?
Galadari, S., Rahman, A., Pallichankandy, S., & Thayyullathil, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.004 · Cited by 893
Cancer therapy in the necroptosis era
Su, Z., Yang, Z., Xie, L., DeWitt, J. P., & Chen, Y. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.8 · Cited by 333
Unraveling the Potential Role of Glutathione in Multiple Forms of Cell Death in Cancer Therapy
Lv, H., Zhen, C., Liu, J., Yang, P., Hu, L., & Shang, P. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3150145 · Cited by 320
“Dimethyl fumarate (DMF) induced typical features of necroptosis-like excessive autophagy, disintegration of mitochondrial membrane potential, LDH release, and accumulation of ROS in colon cancer cells by depleting the cellular GSH level [81].”
BackgroundThe functional roles of TCA cycle metabolites in cancer
Eniafe, J., & Jiang, S. (2021) · Oncogene · doi:10.1038/s41388-020-01639-8 · Cited by 273
HIF-2α activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron
Singhal, R., Mitta, S. R., Das, N. K., Kerk, S. A., Sajjakulnukit, P., Solanki, S., Andren, A., Kumar, R., Olive, K. P., Banerjee, R., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143691 · Cited by 215
Metadata
- Authors
- Xie, X., Zhao, Y., Ma, C., Xu, X., Zhang, Y., Wang, C., Jin, J., Shen, X., Gao, J., Li, N., Sun, Z., & Dong, D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2015-06-12
- Volume
- 172
- Issue
- 15
- Pages
- 3929-3943
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2126990175
- Cited by
- 155
- References
- 10
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.